Bolanowska W - Search Results

1

Absence of seasonal variation in antipyrine metabolism.

Paigen B, Ward E, Steenland K, Bolanowska W, Gessner T, Chang RL, Wood AW, Conney AH. Paigen B, et al. Among authors: bolanowska w. Clin Pharmacol Ther. 1982 Feb;31(2):144-50. doi: 10.1038/clpt.1982.23. Clin Pharmacol Ther. 1982. PMID: 7056021

2

High-pressure liquid chromatographic analysis of benzo(a)pyrene metabolism by human lymphocytes from donors of different aryl hydrocarbon hydroxylase inducibility and antipyrine half-lives.

Gurtoo HL, Vaught JB, Marinello AJ, Paigen B, Gessner T, Bolanowska W. Gurtoo HL, et al. Among authors: bolanowska w. Cancer Res. 1980 Apr;40(4):1305-10. Cancer Res. 1980. PMID: 7357559

3

Drug interactions: inhibition of acetaminophen glucuronidation by drugs.

Bolanowska W, Gessner T. Bolanowska W, et al. J Pharmacol Exp Ther. 1978 Jul;206(1):233-8. J Pharmacol Exp Ther. 1978. PMID: 660554

4

Drug interactions with acetaminophen: effects of phenobarbital, prednisone and 5-fluorouracil in normal and tumor-bearing rats.

Bolanowska W, Gessner T. Bolanowska W, et al. Biochem Pharmacol. 1980 Apr 15;29(8):1167-75. doi: 10.1016/0006-2952(80)90413-x. Biochem Pharmacol. 1980. PMID: 7387732 No abstract available.

5

Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice.

Bolanowska W, Gessner T. Bolanowska W, et al. Xenobiotica. 1982 Feb;12(2):125-36. doi: 10.3109/00498258209046786. Xenobiotica. 1982. PMID: 7090422

6

A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.

Bolanowska W, Gessner T, Preisler H. Bolanowska W, et al. Cancer Chemother Pharmacol. 1983;10(3):187-91. doi: 10.1007/BF00255759. Cancer Chemother Pharmacol. 1983. PMID: 6574828

7

Effects of prior therapy on plasma levels of adriamycin during subsequent therapy.

Gessner T, Robert J, Bolanowska W, Hoerni B, Durand M, Preisler H, Rustum J. Gessner T, et al. Among authors: bolanowska w. J Med. 1981;12(2-3):183-93. J Med. 1981. PMID: 6944425 No abstract available.

8

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia.

Preisler HD, Gessner T, Azarnia N, Bolanowska W, Epstein J, Early AP, D'Arrigo P, Vogler R, Winton L, Chervenik P, et al. Preisler HD, et al. Among authors: bolanowska w. Cancer Chemother Pharmacol. 1984;12(2):125-30. doi: 10.1007/BF00254604. Cancer Chemother Pharmacol. 1984. PMID: 6697426

9

Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy.

Gessner T, Preisler HD, Azarnia N, Bolanowska W, Vogler WR, Grunwald H, Joyce R, Goldberg J. Gessner T, et al. Among authors: bolanowska w. Med Oncol Tumor Pharmacother. 1987;4(1):23-31. doi: 10.1007/BF02934931. Med Oncol Tumor Pharmacother. 1987. PMID: 3600054

10

Dealkylation of tetraethyllead in the homogenates of rat and rabbit tissues.

Bolanowska W, Wiśniewska-Knypl JM. Bolanowska W, et al. Biochem Pharmacol. 1971 Aug;20(8):2108-10. doi: 10.1016/0006-2952(71)90419-9. Biochem Pharmacol. 1971. PMID: 5137972 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters